Abstract:Multiple sclerosis (MS) is a complex chronic neurologic disease with a suspected autoimmune pathogenesis 1 , 2 . Although there is evidence that the development of MS is determined by both environmental influences and genes, these factors are largely undefined 3 , 4 , except for major histocompatibility (MHC) genes. Linkage analyses and association studies have shown that susceptibility to MS is associated with genes in the human histocompatibility leukocyte antigens (HLA) class II region, but the contribution of these genes to MS disease development is less compared with their contribution to disorders such as insulin-dependent diabetes mellitus 5 , 6 , 7 , 8 , 9 , 10 , 11 . Due to the strong linkage disequilibrium in the MHC class II region, it has not been possible to determine which gene(s) is responsible for the genetic predisposition 12 . In transgenic mice, we have expressed three human components involved in T-cell recognition of an MS-relevant autoantigen presented by the HLA-DR2 molecule: DRA*0101 / DRB1*1501 (HLA-DR2), an MHC class II candidate MS susceptibility genes found in individuals of European descent; a T-cell receptor (TCR) from an MS-patient-derived T-cell clone specific for the HLA-DR2 bound immunodominant myelin basic protein (MBP) 84–102 peptide 13 , 14 ; and the human CD4 coreceptor. The amino acid sequence of the MBP 84–102 peptide is the same in both human and mouse MBP. Following administration of the MBP peptide, together with adjuvant and pertussis toxin, transgenic mice developed focal CNS inflammation and demyelination that led to clinical manifestations and disease courses resembling those seen in MS. Spontaneous disease was observed in 4% of mice. When DR2 and TCR double-transgenic mice were backcrossed twice to Rag2 (for recombination-activating gene 2)-deficient mice, the incidence of spontaneous disease increased, demonstrating that T cells specific for the HLA-DR2 bound MBP peptide are sufficient and necessary for development of disease. Our study provides evidence that HLA-DR2 can mediate both induced and spontaneous disease resembling MS by presenting an MBP self-peptide to T cells.

Binding Stretches of Myelin Basic Protein Define Encephalitogenic T Cell Epitopes for RT1.B and RT1.D Alleles of Four Different Rat Haplotypes

Allelic Variations in Rat MHC Class II Binding of Myelin Basic Protein Peptides Correlate with Encephalitogenicity

Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106.

Linking myelin and Epstein-Barr virus specific immune responses in multiple sclerosis: insights from integrated public T cell receptor repertoires

Autoreactive T and B Cells Responding to Myelin Proteolipid Protein in Multiple Sclerosis and Controls.

A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor

Spreading of the immune response to different myelin basic protein peptides in chronic experimental autoimmune encephalomyelitis in B10.RIII mice.

Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model

Modulation of the immune response in multiple sclerosis: production of monoclonal antibodies specific to HLA/myelin basic protein.

Genetic Linkage Analysis of the Antibody Responses to Myelin Basic Protein and Myelin Oligodendrocyte Glycoprotein in Rats Immunized with Rat Spinal Cord Homogenate

Involvement of Degenerating 21.5 kDa Isoform of Myelin Basic Protein in the Pathogenesis of the Relapse in Murine Relapsing-Remitting Experimental Autoimmune Encephalomyelitis and MS Autopsied Brain

Chronic Experimental Autoimmune Encephalomyelitis Induced by the 89‐101 Myelin Basic Protein Peptide in B10RIII (h2r) Mice

[Immune response against myelin basic protein and analysis of T-cell receptor in multiple sclerosis]

Pathogenic myelin-specific antibodies in multiple sclerosis target conformational proteolipid protein 1-anchored membrane domains

Major Histocompatibility Complex-Controlled Protective Influences on Experimental Autoimmune Encephalomyelitis Are Peptide Specific.

Proliferative Responses of T Cell Lines from Multiple Sclerosis Patients to Different Myelin Compositions

The Major Histocompatibility Complex Influences Myelin Basic Protein 63–88 Induced T Cell Cytokine Profile and Experimental Autoimmune Encephalomyelitis

T-Cell And B-Cell Responses To Myelin-Oligodendrocyte Glycoprotein In Multiple-Sclerosis

Autoimmune responses to myelin-associated proteins as diagnostic and prognostic biomarkers of relapsing-remitting multiple sclerosis: associations with human herpesvirus-6 and Epstein-Barr Virus reactivation.

A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model

Neuronal molecular mimicry in immune‐mediated neurologic disease